Abstract
The pharmacokinetics of ampicillin and sulbactam, a new beta-lactamase inhibitor, were investigated in 16 patients undergoing prosthetic cardiac valve insertion. The combination of 2 g of ampicillin and 1 g of sulbactam was administered as perioperative prophylaxis intravenously over 3 to 6 days. Several serum pharmacokinetic parameters were similar for the two drugs after three intravenous doses were given to patients following surgery. The half-lives of elimination of ampicillin and sulbactam were 79 +/- 4.9 and 88 +/- 5.9 min, the volumes of distribution were 15.6 +/- 1.4 and 17.7 +/- 1.2 liters/70 kg, and the total plasma clearances were 144.4 +/- 14.5 and 147.2 +/- 14.5 ml/min, respectively. The peak concentrations of ampicillin and sulbactam in serum were calculated to be 134.3 +/- 1.3 and 58.3 +/- 1.2 micrograms/ml, respectively. Ampicillin and sulbactam rapidly penetrated from the blood into various tissues collected during heart surgery, such as sternum, pericardium, myocardium, and endocardium. The concentrations of ampicillin in tissue ranged from 17.8 +/- 9.9 to 50 +/- 29.5 micrograms/g, and those of sulbactam in tissue ranged from 8.8 +/- 6.2 to 19.6 +/- 10.1 micrograms/g. The concentrations of ampicillin and sulbactam in serum and tissue also apparently exceeded the MICs against most beta-lactamase-producing bacteria usually involved in postoperative wound infections and prosthetic valve endocarditis. The ratio of the two compounds was approximately 2:1 in serum and in the various tissues affected by the operation. The pharmacokinetics of ampicillin and sulbactam in serum and investigated tissues suggest that the combination of the two beta-lactams will be effective in the perioperative prophylaxis of patients undergoing heart surgery.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bozler G., Heinzel G., Koss F. W., Wolf M. Modellentwicklung in her Pharmakokinetik. I. Teil: Allgemeine Strategie. Arzneimittelforschung. 1977;27(4A):897–900. [PubMed] [Google Scholar]
- Daschner F. D., Langmaack H., Spillner G., Ahmadi A., Schlosser V. Penetration of cephradine into heart valves, subcutaneous tissue and muscle of patients undergoing open heart surgery. J Antimicrob Chemother. 1979 Nov;5(6):711–715. doi: 10.1093/jac/5.6.711. [DOI] [PubMed] [Google Scholar]
- DiPiro J. T., Record K. E., Schanzenbach K. S., Bivins B. A. Antimicrobial prophylaxis in surgery: part 2. Am J Hosp Pharm. 1981 Apr;38(4):487–494. [PubMed] [Google Scholar]
- Engel K., Wildfeuer A. Perioperative systemic antibiotics for prophylaxis of infections in breast surgery: sulbactam/ampicillin versus mezlocillin/oxacillin. Suppl Int J Gynecol Obstet. 1989;2:29–34. doi: 10.1016/0020-7292(89)90089-1. [DOI] [PubMed] [Google Scholar]
- English A. R., Retsema J. A., Girard A. E., Lynch J. E., Barth W. E. CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization. Antimicrob Agents Chemother. 1978 Sep;14(3):414–419. doi: 10.1128/aac.14.3.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fong I. W., Baker C. B., McKee D. C. The value of prophylactic antibiotics in aorat-coronary bypass operations: a double-blind randomized trial. J Thorac Cardiovasc Surg. 1979 Dec;78(6):908–913. [PubMed] [Google Scholar]
- Gentry L. O., Zeluff B. J., Cooley D. A. Antibiotic prophylaxis in open-heart surgery: a comparison of cefamandole, cefuroxime, and cefazolin. Ann Thorac Surg. 1988 Aug;46(2):167–171. doi: 10.1016/s0003-4975(10)65890-0. [DOI] [PubMed] [Google Scholar]
- Houang E. T., Reardon P. Single dose intramuscular sulbactam and ampicillin in treating acute uncomplicated gonorrhoea. Genitourin Med. 1985 Jun;61(3):209–209. doi: 10.1136/sti.61.3.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Löffler L., Bauernfeind A., Keyl W. Sulbactam/ampicillin versus cefotaxime as initial therapy in serious soft tissue, joint and bone infections. Drugs. 1988;35 (Suppl 7):46–52. doi: 10.2165/00003495-198800357-00012. [DOI] [PubMed] [Google Scholar]
- Wildfeuer A., Schwiersch U., Engel K., von Castell E., Schilling A., Potempa J., Lenders H. Pharmacokinetics of sulbactam and ampicillin intravenously applied in combination to healthy volunteers and patients. Determination of the ratio of the two drugs in serum and in various tissues. Arzneimittelforschung. 1988 Nov;38(11):1640–1643. [PubMed] [Google Scholar]
- de la Hunt M. N., Karran S. J. Sulbactam/ampicillin compared with cefoxitin for chemoprophylaxis in elective colorectal surgery. Dis Colon Rectum. 1986 Mar;29(3):157–159. doi: 10.1007/BF02555011. [DOI] [PubMed] [Google Scholar]